Anthracycline-induced Cardiotoxicity
📧 Sign up to get email alerts when something new happens for Anthracycline-induced Cardiotoxicity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is assessing whether the nutritional supplement sulforaphane can protect against doxorubicin-related cardio…
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Ivabradine to Prevent Anthracycline-induced Cardiotoxicity [Phase 3]
A Phase 3 clinical trial evaluating ivabradine to prevent cardiotoxicity from anthracycline chemotherapy in patients with cancer.